Cancer Stem Cells Make a Splash | GenomeWeb

In Cell, Eric Lander and his colleagues report on an approach to screen for compounds that selectively target cancer stem cells. Using that technique, they found that salinomycin, which has "selective toxicity for breast CSCs", leads to a greater than 100-fold reduction in the amount of CSC, as compared to paclitaxel, a chemotherapy drug used to treat breast cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.